Whitehawk Therapeutics, Inc.
WHWK
$1.90
$0.031.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.30% | 0.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.30% | 0.37% | |||
| Cost of Revenue | -36.92% | 40.14% | |||
| Gross Profit | 69.57% | -120.06% | |||
| SG&A Expenses | 15.96% | 53.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.61% | 45.59% | |||
| Operating Income | 19.69% | -75.86% | |||
| Income Before Tax | 499.58% | -45.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 499.58% | -45.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 499.58% | -45.65% | |||
| EBIT | 19.69% | -75.86% | |||
| EBITDA | 19.79% | -76.19% | |||
| EPS Basic | 373.04% | -45.39% | |||
| Normalized Basic EPS | 46.04% | -84.10% | |||
| EPS Diluted | 371.27% | -45.39% | |||
| Normalized Diluted EPS | 46.44% | -84.10% | |||
| Average Basic Shares Outstanding | 46.35% | 0.17% | |||
| Average Diluted Shares Outstanding | 47.42% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||